These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 3399498)

  • 21. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of antipeptide antisera.
    Coligan JE; Tam JP; Shao J
    Curr Protoc Neurosci; 2001 May; Chapter 5():Unit 5.6. PubMed ID: 18428505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of anti-peptide antisera.
    Carter JM
    Curr Protoc Immunol; 2003 Aug; Chapter 9():Unit 9.3. PubMed ID: 18432916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design.
    Moreno R; Jiang L; Moehle K; Zurbriggen R; Glück R; Robinson JA; Pluschke G
    Chembiochem; 2001 Nov; 2(11):838-43. PubMed ID: 11948870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier-bound synthetic peptides. Use as antigen in HIV-1 ELISA tests and in antiserum production.
    Modrow S; Höflacher B; Mertz R; Wolf H
    J Immunol Methods; 1989 Mar; 118(1):1-7. PubMed ID: 2926144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
    Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
    Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved method for utilization of peptide substrates for antibody characterization and enzymatic assays.
    Ghosh I; Sun L; Evans TC; Xu MQ
    J Immunol Methods; 2004 Oct; 293(1-2):85-95. PubMed ID: 15541279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors.
    Traish AM; Wotiz HH
    Endocrinology; 1990 Sep; 127(3):1167-75. PubMed ID: 2201532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the multipin peptide synthesis technique for the generation of antipeptide sera.
    Triantafyllou B; Tribbick G; Maeji NJ; Geysen HM
    Cell Biophys; 1992; 21(1-3):33-52. PubMed ID: 1285329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
    Cachia PJ; Kao DJ; Hodges RS
    J Mol Recognit; 2004; 17(6):540-57. PubMed ID: 15386623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody to synthetic somatostatin-28(1-12): immunoreactivity with somatostatin in brain is dependent on orientation of immunizing peptide.
    Lipkin WI; Schwimmbeck PL; Oldstone MB
    J Histochem Cytochem; 1988 Apr; 36(4):447-51. PubMed ID: 2450123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J; Yu F; Cease KB
    J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of human renin antibodies prepared with synthetic immunogens.
    Galen FX; Evin G; Carelli C; Bouhnik J; Michel JB; Ferhentz JA; Le N'Guyen D; Seyer R; Carlson WD; Haber E
    J Hypertens Suppl; 1987 Dec; 5(5):S11-4. PubMed ID: 2450977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
    Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an enzyme-linked immunosorbent assay for the determination of the linear alkylbenzene sulfonates and long-chain sulfophenyl carboxylates using antibodies generated by pseudoheterologous immunization.
    Ramón-Azcón J; Galve R; Sánchez-Baeza F; Marco MP
    Anal Chem; 2006 Jan; 78(1):71-81. PubMed ID: 16383312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
    Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
    J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.
    Zhong G; Toth I; Reid R; Brunham RC
    J Immunol; 1993 Oct; 151(7):3728-36. PubMed ID: 7690812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.